| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 107043 | Null | 0.0219024304994663 | 0.048035754 |
| NSC 120925 | Null | 0.0219024304994663 | 0.57525411 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0219024304994663 | 0.11584046 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0219024304994663 | 0.10309689 |
| NSC 149765 | 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) | 0.0219024304994663 | -0.071489357 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0219024304994663 | 0.27795174 |
| NSC 208885 | Null | 0.0219024304994663 | 0.39859118 |
| NSC 287069 | Epicorazine A | 0.0219024304994664 | 0.052471342 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.0219024304994664 | 0.47222511 |
| NSC 319947 | 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- | 0.0219024304994664 | 0.31798638 |